BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28331341)

  • 21. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
    Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
    Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.
    Cantariño N; Musulén E; Valero V; Peinado MA; Perucho M; Moreno V; Forcales SV; Douet J; Buschbeck M
    Mol Cancer Res; 2016 Sep; 14(9):841-8. PubMed ID: 27280713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptidyl arginine deiminase 2 (Padi2) is expressed in Sertoli cells in a specific manner and regulated by SOX9 during testicular development.
    Tsuji-Hosokawa A; Kashimada K; Kato T; Ogawa Y; Nomura R; Takasawa K; Lavery R; Coschiera A; Schlessinger D; Harley VR; Takada S; Morio T
    Sci Rep; 2018 Sep; 8(1):13263. PubMed ID: 30185873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The lncRNA HOXA11-AS functions as a competing endogenous RNA to regulate PADI2 expression by sponging miR-125a-5p in liver metastasis of colorectal cancer.
    Chen D; Sun Q; Zhang L; Zhou X; Cheng X; Zhou D; Ye F; Lin J; Wang W
    Oncotarget; 2017 Sep; 8(41):70642-70652. PubMed ID: 29050308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolutionary analysis reveals the role of a non-catalytic domain of peptidyl arginine deiminase 2 in transcriptional regulation.
    Villanueva-Cañas JL; Fernandez-Fuentes N; Saul D; Kosinsky RL; Teyssier C; Rogalska ME; Pérez FP; Oliva B; Notredame C; Beato M; Sharma P
    iScience; 2024 Apr; 27(4):109584. PubMed ID: 38623337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protein citrullination as a source of cancer neoantigens.
    Katayama H; Kobayashi M; Irajizad E; Sevillarno A; Patel N; Mao X; Rusling L; Vykoukal J; Cai Y; Hsiao F; Yu CY; Long J; Liu J; Esteva F; Fahrmann J; Hanash S
    J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34112737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of lncRNA Fez family zinc finger protein 1 antisense RNA1 in hepatocellular carcinoma].
    Yao J; Wang XP; Zhang ZZ; Yang J; Yang Z; Qian HX
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):667-674. PubMed ID: 31550856
    [No Abstract]   [Full Text] [Related]  

  • 29. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of siRNA-silencing of SALL2 gene on growth, migration and invasion of human ovarian carcinoma A2780 cells.
    Miao F; Zhang X; Cao Y; Wang Y; Zhang X
    BMC Cancer; 2017 Dec; 17(1):838. PubMed ID: 29228922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARHGEF10L contributes to liver tumorigenesis through RhoA-ROCK1 signaling and the epithelial-mesenchymal transition.
    Tang J; Liu C; Xu B; Wang D; Ma Z; Chang X
    Exp Cell Res; 2019 Jan; 374(1):46-68. PubMed ID: 30444969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased peptidylarginine deiminases expression during the macrophage differentiation and participated inflammatory responses.
    Lai NS; Yu HC; Tung CH; Huang KY; Huang HB; Lu MC
    Arthritis Res Ther; 2019 Apr; 21(1):108. PubMed ID: 31039829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
    Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer.
    Gijon M; Metheringham RL; Toss MS; Paston SJ; Durrant LG
    Pathobiology; 2022; 89(1):38-48. PubMed ID: 34569542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effects of FPR2 gene silencing on the proliferation, migration and invasion of human glioma U87 cells].
    Liu L; Li X; Shi J; Li L; Wang J; Luo ZZ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):659-666. PubMed ID: 30293389
    [No Abstract]   [Full Text] [Related]  

  • 38. Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease.
    Kim Y; Rebman AW; Johnson TP; Wang H; Yang T; Colantuoni C; Bhargava P; Levy M; Calabresi PA; Aucott JN; Soloski MJ; Darrah E
    Front Neurol; 2022; 13():874211. PubMed ID: 35734473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
    Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
    World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
    Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
    Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.